oseltamivir phosphate

DRUG6 trials

Sponsors

Novartis, Daiichi Sankyo Co., Ltd., Adamas Pharmaceuticals, Inc., Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, GlaxoSmithKline

Conditions

HealthyInfluenzaInfluenza, HumanSevere InfluenzaVirus Diseases

Phase 1

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

CompletedNCT00416962

NovartisHealthy

Start: 2006-08-31End: 2006-12-31Target: 18Updated: 2007-11-30

Phase 2

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

CompletedNCT00979251

Adamas Pharmaceuticals, Inc.Influenza

Start: 2009-09-30End: 2011-08-31Updated: 2014-04-14

Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza

CompletedNCT02469298

GlaxoSmithKlineVirus Diseases

Start: 2015-06-01End: 2016-04-25Updated: 2019-07-23

Phase 3

A Multinational Phase III Study of CS-8958 (MARVEL)

CompletedNCT00803595

Daiichi Sankyo Co., Ltd.Influenza, Human

Start: 2008-11-30End: 2009-06-30Updated: 2019-01-09

Phase 4

Banlangen Granules Anti-seasonal Influenza Study

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company LimitedInfluenza

Start: 2012-04-30End: 2016-11-30Target: 177Updated: 2016-03-04

Unknown Phase

Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

Jiangxi Qingfeng Pharmaceutical Co. Ltd.Severe Influenza

Start: 2019-03-04End: 2020-03-31Target: 72Updated: 2019-05-15

Related Papers

Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial.

2015-03-2815 citations

Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

2010-10-11149 citations

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.

2007-12-1243 citations